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Objective: The aim was to determine whether lower visceral pain thresholds in irritable bowel syndrome (IBS)
primarily reflect physiological or psychological factors.
Methods: Firstly, 121 IBS patients and 28 controls underwent balloon distensions in the descending colon
using the ascending methods of limits (AML) to assess pain and urge thresholds. Secondly, sensory decision
theory analysis was used to separate physiological from psychological components of perception:
neurosensory sensitivity (p(A)) was measured by the ability to discriminate between 30 mm Hg vs
34 mm Hg distensions; psychological influences were measured by the report criterion—that is, the overall
tendency to report pain, indexed by the median intensity rating for all distensions, independent of intensity.
Psychological symptoms were assessed using the Brief Symptom Inventory (BSI).
Results: IBS patients had lower AML pain thresholds (median: 28 mm Hg vs 40 mm Hg; p,0.001), but
similar neurosensory sensitivity (median p(A): 0.5 vs 0.5; p = 0.69; 42.6% vs 42.9% were able to discriminate
between the stimuli better than chance) and a greater tendency to report pain (median report criterion: 4.0
(‘‘mild’’ pain) vs 5.2 (‘‘weak’’ pain); p = 0.003). AML pain thresholds were not correlated with neurosensory
sensitivity (r = 20.13; p = 0.14), but were strongly correlated with report criterion (r = 0.67; p,0.0001).
Report criterion was inversely correlated with BSI somatisation (r = 20.26; p = 0.001) and BSI global score
(r = 20.18; p = 0.035). Similar results were seen for the non-painful sensation of urgency.
Conclusion: Increased colonic sensitivity in IBS is strongly influenced by a psychological tendency to report
pain and urge rather than increased neurosensory sensitivity.
D
uring balloon distension of the rectum or colon patients
with irritable bowel syndrome (IBS) report pain and
discomfort at abnormally low volumes or pressures.1–3
These lower pain thresholds have been interpreted to represent
visceral hypersensitivity4 5 and have been attributed to physio-
logical differences in IBS patients.6–8 Mertz et al even proposed
that lower pain thresholds are ‘‘a reliable biological marker of
IBS.’’9 However, it is impossible to attribute lower IBS pain
thresholds specifically to underlying physiological mechan-
isms3 10 since cognitive and psychological influences affect the
reporting of pain and, by extension, affect threshold measure-
ments.1 11 12
The physiological and psychological components that deter-
mine pain thresholds can be separately quantified by sensory
decision theory analysis (SDT).13 In SDT stimuli of different
intensities are presented in an unpredictable order and subjects
rate the intensity of each stimulus. Statistical decision theory is
then used to determine:
(1) The discrimination index (p(A)): a measure of neurosensory
sensitivity (physiological) that is based on the subject’s
ability to discriminate between two stimuli of similar, yet
distinct, intensities. The discrimination index is reduced by
local nerve blocks and analgesics, but is immune to
cognitive and psychological manipulations.14 15
(2) The report criterion (B): a measure of the subject’s overall
tendency to label any stimuli as weak vs intense,
independent of the actual stimulus intensity. The report
criterion is susceptible to cognitive and psychological
manipulations such as suggestion and placebo, but is not
affected by analgesics.14–16
The primary aim of this study was to determine whether
differences in pain thresholds between patients with IBS and
healthy controls are explained primarily by differences in
neurosensory sensitivity (physiological differences) or differ-
ences in the overall tendency to report pain (psychological
differences). The secondary aim was to determine and explain
differences in urge thresholds. Ultimately, a better under-
standing of the factors that affect these thresholds will improve
our understanding of the mechanisms responsible for hyper-
sensitivity and might help to direct therapy. Accordingly, we
used AML to compare sensory thresholds in both IBS patients
and healthy controls, and SDT supplemented by psychological
questionnaires to determine how physiological and psycholo-
gical factors contribute to these thresholds. We hypothesised
that, compared to healthy controls, IBS patients would have:
(1) lower AML determined pain and urge thresholds; (2)
similar levels of neurosensory sensitivity; and (3) a lower report
criterion (that is, an increased overall tendency to report stimuli
as intense). (4) We also hypothesised that AML pain thresholds
and the report criterion would be inversely correlated with
levels of psychological distress.
Abbreviations: AML, ascending methods of limits; BSI, Brief Symptom
Inventory; IBS, irritable bowel syndrome; IBS-C, constipation predominant
irritable bowel syndrome; IBS-D, diarrhoea predominant irritable bowel
syndrome; IOP, individual operating pressure; ROC, receiver operator





Subjects were recruited by advertisements or physician referrals
and screened by telephone. The study was approved by the
institutional review board of the University of North Carolina
(UNC) and all subjects provided informed consent.
IBS patients
The study population consisted of 132 patients (84% female;
median age 35 years) who met Rome II criteria for IBS17 and
had current symptom activity (abdominal pain at least once a
week in the past month). Twenty-seven IBS patients were
constipation predominant (IBS-C), 31 were diarrhoea predo-
minant IBS (IBS-D), and 61 were not classifiable as either.
These subjects had no history of gastrointestinal resection
(other than appendectomy or cholecystectomy), known IBS,
coeliac disease, lactose malabsorption, heart disease, or diabetes
mellitus, and they were not pregnant at the time of study. IBS
patients were required to stop the following medications—
antidepressants (seven days before study), antispasmodics,
muscle relaxants or narcotic analgesics (three days); and non-
steroidal anti-inflammatory agents (one day).
Controls
The control population consisted of 31 subjects (71% female;
median age 40 years) without any significant or recurring
gastrointestinal symptoms; exclusion criteria were average stool
frequency of less than three per week or more than three per
day, abdominal pain, use of a laxative or anti-diarrhoeal agent
on more than two occasions over the previous year, history of
alcohol or substance abuse, a psychiatric diagnosis, or any of
the medical conditions listed above for the IBS patients. None
of these healthy subjects had used any antidepressants,
antispasmodics, muscle relaxants, or narcotic analgesics for at
least one year. Non-steroidal anti-inflammatory agents were
not permitted for at least one day before the study. There were
no significant differences between the IBS group and healthy
controls for age (p = 0.72) or sex (p = 0.12).
Psychological evaluation
On the first day of the study subjects reported to the UNC
General Clinical Research Center (GCRC) at 11 am where they
completed the Brief Symptom Inventory-18 (BSI-18). This is an
18-item measure of psychological distress along three primary
symptom dimensions: somatisation, anxiety, and depression.18
The BSI-18 was also scored for the global severity index. The
rationale for including the BSI somatisation scale is that
somatic hypervigilance is hypothesised to play a part in visceral
hypersensitivity.12 The BSI depression, anxiety, and global
scales were included based on the convention of regarding
depression and anxiety as the primary dimensions of psycho-
logical distress.
Colonic sensory testing
At approximately 4 pm subjects underwent bowel preparation
with 3 oz of Fleets Phospho-Soda followed by an overnight fast.
On the morning of the second day (approximately 8 am) a
barostat catheter was placed into the descending colon for
sensory testing. Firstly, a guide wire was inserted to the level of
the splenic flexure using a flexible sigmoidoscope. The
sigmoidoscope was then withdrawn and a barostat catheter
(Model No C7-CB-0026, Mui Scientific, Mississauga, Ontario,
Canada) was inserted over the guide wire. The guide wire was
then withdrawn and barostat placement was confirmed by
fluoroscopy. No sedation was used throughout the duration of
this procedure. A 600 ml plastic bag (Model No CT-BP600R,
Mui Scientific, Mississauga, Ontario, Canada) was attached to
the catheter, and the catheter was connected to a computer
controlled piston type pump (barostat) that was capable of
inflating and deflating the bag at a rate of 38 ml/s (G&J
Electronics, Willodale, Ontario, Canada). The pump was
interfaced to a computer running a software program that
recorded the pressure inside the bag 16 times per second.
Subjects were instructed to give separate ratings of the
intensity of pain and urgency to defecate experienced at the end
of each distension, using a six point scale (0 = no sensation;
1 = weak; 2 = mild; 3 = moderate; 4 = strong; 5 = intense)
(fig 1). The scale was visible to subjects during the procedure.
Sample distensions were then performed during which the
barostat bag was inflated in a stepwise fashion by increasing
bag pressure by 4 mm Hg every 15 seconds until the subject
reported moderate pain (rating of 3). The purpose of the sample
distensions was threefold: (1) to insure that the barostat bag
was unfolded; (2) to teach the subject how to use the rating
scale to rate the intensity of colonic sensations; and (3) to
decrease anticipatory anxiety. The barostat bag was then slowly
inflated with 30 ml of air and the pressure was allowed to
equilibrate for 3 minutes. The average pressure during the last
15 seconds defined the individual operating pressure (IOP): the
minimum pressure required to overcome mechanical forces and
inflate the bag with 30 ml of air.
Figure 1 Subjects rated the intensity of each stimulus on the six point
rating scale showed above. The corresponding descriptor and beta value
for each numeric rating are shown. Boundaries separate consecutive
ratings.
Figure 2 Receiver operator characteristic curve (ROC curve): each point
represents the proportion of hits and false alarms for a given boundary
(b1–b5). The total area under the ROC curve represents p(A).
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Ascending method of limits (AML) protocol
This protocol started approximately 90 minutes following barostat
placement. Phasic distensions were 30 seconds in duration and
were separated by 30-second rest intervals starting at the IOP and
progressively increasing in 2 mm Hg steps until either the subject
requested the research nurse to stop the protocol or 48 mm Hg
was reached. The pain threshold was defined as the amount of
pressure above IOP at which the subject first reported moderate
pain (absolute distending pressure minus the IOP). If the subject
requested that the research nurse stop the trial before moderate
pain was reported (for example, because of urge to defecate) then
the pain threshold was not determined. If the subject reached
48 mm Hg without reporting moderate pain, then the pain
threshold was defined as 50 mm Hg minus the IOP. The urge
threshold was defined analogously.
Sensory decision theory (SDT) protocol
This protocol started approximately 100 minutes following
barostat placement. Subjects were instructed that the purpose
was to evaluate how well they could discriminate between
different balloon pressures. Twenty-four 30-second phasic
distensions (eight at 30 mm Hg, eight at 32 mm Hg, and eight
at 34 mm Hg) were presented in an unpredictable order
separated by 30-second rest intervals at the IOP. These stimulus
intensities were selected to bracket the average pain threshold
determined by AML in a previous study of SDT.19 The choice of
2 mm Hg increments between stimuli was based on this
previous study in which this difference was found to work
well (that is, subjects made some errors of classification but
discrimination was better than chance).19 This protocol fol-
lowed the recommendation of McNicol20 and one of the co-
investigators who is an expert on SDT (WCC). The subjects
were able to stop the protocol at any time.
Discrimination index (p(A)) and report criterion (B) values
for the 30 mm Hg vs 34 mm Hg stimuli were calculated for each
subject using a computer program developed by MN Janal and
WC Clark (personal communication). This program was based
on formulas taken from McNicol for non-parameteric SDT
analysis of rating scale data.20
The meaning of the discrimination index (p(A)) is clear: it is
a measure of the ability to distinguish between the two
stimulus intensities, based on the sensory intensity ratings
reported in response to them. However, the computational
formula is complex: (1) ratings on the rating scale used by the
subject to subjectively rate the intensity of stimuli that are
presented, are separated by multiple boundaries (fig 1). (2) For
each boundary one calculates the proportion of all the higher
intensity stimuli (that is, 34 mm Hg distensions) that received
ratings above this boundary (this is the ‘‘hit’’ rate for this
boundary) and one separately calculates the proportion of the
lower intensity stimuli (that is, 30 mm Hg distensions) that
received ratings above this boundary (this is the ‘‘false alarm’’
rate for this boundary). Thus, in this study hit rates and false
alarm rates were calculated for each of five boundaries. (3)
These hit rates and false alarm rates are plotted against each
other to create a receiver operator characteristic curve (ROC
curve) as shown in figure 2. The curve is drawn by connecting
the different intersections of hit and false alarm rates calculated
for each boundary (shown by the solid line in fig 2). (4) P(A) is
the total area under the ROC curve (shaded area in fig 2)
expressed as a proportion of the maximum possible area. The
broken diagonal line in figure 2 goes through all the points for
which the hit rate and the false alarm rates are equal; this
represents chance performance or no discrimination, and the
index, p(A) is 0.5. All values less than 0.5 are considered chance
performance and are rounded up to 0.5. Thus, p(A) is a number
between 0.5 (chance) and 1.0 (perfect discrimination) that
measures the ability to discriminate between the two intensities
independently of what rating labels the subject uses to describe
the stimuli.
The report criterion (B) is the median rating assigned by the
subjects to all stimuli. Firstly, the ratings assigned to the
Figure 3 (Top left) Median AML pain
thresholds: thresholds were significantly
higher in healthy controls than in IBS
subjects. (Top right) The pain report criterion
(B) across both 30 mm Hg and 34 mm Hg
stimuli: IBS patients had a lower criterion,
which reflects their increased tendency to
report pain irrespective of stimulus intensity.
(Bottom left) The median pain neurosensory
sensitivity (p(A)). There were no differences
between the two groups. (Bottom right) The
percentage of subjects whose ability to
discriminate painful sensations between
30 mm Hg and 34 mm Hg stimuli was better
than chance (p(A).0.5): there was no
difference between the two groups. The bars
on each graph represent the interquartile
range.
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30 mm Hg distensions were pooled with ratings for the
34 mm Hg distensions. Secondly, each response on the six-
point rating scale was assigned an individual report criterion
(B) value. Based on SDT convention, a numerically low
criterion means a ‘‘liberal’’ tendency to rate most of the stimuli
as intense, whereas a numerically high criterion means a
‘‘conservative’’ or ‘‘stoic’’ tendency to label most stimuli as less
intense. Therefore, higher (that is, more intense) subject ratings
are assigned lower B values and vice versa (fig 2). Thirdly, the
overall report criterion (B) was determined as the B value on
the six point rating scale for which half of total responses to
both stimulus intensities were to categories above the criterion
and half were to categories below the criterion.13
There was a strong correlation between AML pain thresholds
and pain report criterion (r = 0.67 p,0.0001). On the contrary,
AML pain thresholds did not correlate with neurosensory
sensitivity for pain (r = 20.13; p = 0.14).
Data analysis
The data were not normally distributed. Consequently, non-
parameteric statistical tests were used. Significance was set at a
p value of 0.05. Firstly, Wilcoxon rank sum tests were used to
compare IBS patients to controls with respect to the following
measures: AML determined pain and urge thresholds; SDT
determined pain and urge discrimination index (p(A)) and
report criterion values (B); BSI anxiety, depression, somatisa-
tion, and global severity index scores. Secondly, Spearman
correlations were used to determine associations between AML
pain thresholds with SDT determined pain discrimination index
(p(A)) and report criterion (B). Thirdly, Spearman correlations
were used to determine associations between both AML pain
thresholds and pain report criteria (B) with the following
measures: p(A), BSI anxiety, depression, somatisation, and
global severity index scores.
RESULTS
Excluded subjects
In all, 119 IBS patients and 29 control subjects underwent
colonic sensory testing. Of the 13 IBS patients who did not
undergo colonic sensory testing, three withdrew consent after
the first day, possibly because of apprehension regarding the
pain test procedure, three refused flexible sigmoidoscopy, two
did not tolerate sigmoidoscopy, one had an extremely elevated
blood pressure, and one had colonic inflammation detected on
sigmoidoscopy. Of the three excluded control subjects, one did
not tolerate the flexible sigmoidoscopy and two had exclu-
sionary medical conditions that were detected during the study
(lactose intolerance in one and previous colonic surgery in the
other).
Pain thresholds, neurosensory sensitivity, and report
criterion
On the AML protocol IBS patients had lower pain thresholds
(median 28 mm Hg vs 40 mm Hg; p = 0.0002). On sensory
decision theory analysis there were no differences in pain
neurosensory sensitivity (median p(A): 0.5 vs 0.5; p = 0.69;
42.6% of IBS patients vs 42.9% of healthy controls had p(A)
.0.5 (chance); p = 0.98). Conversely, IBS patients had a lower
pain report criterion, which represents their increased tendency
to report stimuli as being relatively painful irrespective of the
actual intensity of the stimulus (median B: 4.0 (median
response = mild pain) vs 5.2 (median response = weak
pain); p = 0.003) (fig 3).
Psychometric scores and pain report criterion
IBS patients scored higher than controls on all psychometric
scales (table 1). There were modest inverse correlations
between pain report criterion (B) and BSI global score
(r = 20.18; p = 0.035) and BSI somatisation (r = 20.26;
p = 0.001) (table 2). Higher psychological distress correlated
with an increased tendency to report pain.
Urge thresholds, neurosensory sensitivity, and report
criterion
Sensory thresholds for urge were lower than those for pain. On
the AML protocol IBS patients had lower urge thresholds than
controls (median: 18 mm Hg vs 34 mm Hg; p = 0.002), but on
sensory decision theory analysis there were no differences in
urge neurosensory sensitivity (median p(A): 0.55 vs 0.50;
p = 0.17; 63.1% of IBS patients vs 46.4% of healthy controls had
urge p(A) .0.5 (chance); p = 0.10). Conversely, IBS patients
had a lower urge report criterion, which represents their
increased tendency to report relatively intense urge irrespective
of the actual intensity of the stimulus (median B: 3.0 (median
response = ‘‘moderate’’ urge) vs 4.2 (median response =
‘‘mild’’); p = 0.006) (fig 4).
There was a strong inverse correlation between AML urge
thresholds and urge report criterion (r = 20.51; p,0.0001) and
a weaker but significant inverse correlation with neurosensory
sensitivity to urge (r = 20.22; p = 0.007).
Psychometric scores and urge report criterion
There were modest inverse correlations between urge report
criterion (B) and BSI global score (r = 20.19; p = 0.03), BSI
somatisation (r = 20.18; p = 0.04), and BSI anxiety (r = 20.17;
p = 0.05) (table 3). Higher psychological distress correlated
with an increased tendency to report urge.
Additional analyses of SDT data
There was a moderately strong positive correlation between
pain and urge discrimination (p(A)) (r = 0.50; p,0.0001).
Similarly, there was a moderately strong positive correlation
between pain and urge report criteria (B) r = 0.44; p,0.0001).
The SDT test involved 24 distensions at pressures, which
were painful for most subjects, and consequently some subjects
did not complete all trials. The accuracy of discrimination index
(p(A)) and report criterion (B) values in subjects who under-
went fewer SDT distension trials might have been lower
because of increased variance. We therefore excluded subjects
who completed fewer than one-half (,12) of all trials (33 IBS,
4 controls, p = 0.158) and repeated the comparison between
IBS patients and controls for pain p(A) and report criterion (B).
The pattern of results and the significance of the differences did
not change for pain p(A) (median p(A) 0.5 vs 0.5; p = 0.31; %
with pain p(A) . chance: IBS = 47.1%; control = 41.7%;
p = 0.63;) or pain report criterion (median B: IBS = 4.4;
control = 5.4; p = 0.0001).
Repeated distension of the colon has been previously shown
to induce hyperalgesia (‘‘sensitisation’’) in IBS patients.8 Thus,
it is possible that as a result of this potential sensitisation, the
intensity ratings made by IBS patients to late SDT trials may








49 (33–78) 42 (33–63) ,0.0001
BSI anxiety 50 (38–74) 39 (38–61) ,0.0001
BSI depression 48 (40–81) 42 (40–61) = 0.006
BSI somatisation 55 (41–74) 41 (41–66) ,0.0001
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have been affected. In order to test for this we first determined
the change in pain intensity ratings between the first and the
last 30 mm Hg and 34 mm Hg trials (change in ratings = pain
intensity rating to the last 30 mm Hg stimuli plus pain intensity
rating to the last 34 mm Hg stimuli minus pain intensity ratings
to the first 30 mm Hg stimuli minus pain intensity rating to the
first 34 mm Hg stimuli). We then used the Wilcoxon rank sum
test of differences to compare change in intensity ratings
between IBS patients and controls who completed at least one-
half (>12) of all trials. There was no difference between the
two groups (p = 0.22).
Finally, the intensities of the three SDT stimuli (30 mm Hg,
32 mm Hg, 34 mm Hg) were below AML pain thresholds for
some subjects (mostly controls) and above threshold for other
subjects (mostly IBS patients). Therefore, it was possible that
certain subjects failed to demonstrate discrimination (p(A))
because they assigned the same ratings to all stimuli (either
calling all of them ‘‘intense’’ or calling all of them non-painful).
We identified nine (7.4%) IBS patients and nine (35%) healthy
controls who rated each SDT stimulus as zero pain intensity.
One IBS patient rated all stimuli as ‘‘intense.’’ All other subjects
varied their pain intensity ratings. When we excluded the 10
IBS patients and nine healthy controls who did not vary their
pain intensity ratings and repeated the analysis, the pattern of
results and the significance of the differences did not change
for pain p(A) (median p(A) 0.5 vs 0.52; p = 0.8); percentage
with pain p(A) . chance: IBS = 45.6%; control = 52.2%;
p = 0.57) or pain report criterion (median B: IBS = 3.9;
control = 4.52; p = 0.04).
DISCUSSION
In this study we first used AML to measure pain and urge
thresholds and we then used SDT to determine the two
components of these thresholds: physiologically determined
neurosensory sensitivity and psychologically determined report
criterion. Using these techniques, we demonstrated that lower
AML determined pain and urge thresholds in patients with IBS
are explained primarily by an increased tendency to report pain
and urge, not increased neurosensory sensitivity. Since this
lower report criterion reflects psychological phenomena,
increased colonic sensitivity in IBS appears to be determined
more by psychological factors than by physiological factors.
Pain is a complex perceptual experience that can only be
measured indirectly.21 Gastrointestinal pain sensitivity is typically
measured by pain thresholds, which are defined as the lowest
stimulus intensity to which subjects report pain. However, pain
Table 2 Spearman’s correlations: AML pain threshold and
pain report criterion (B)
Correlation (rho) with
AML pain threshold
Correlation (rho) with SDT pain
report criterion (B)
Pain p(A) 20.13 p = 0.1 20.16 p = 0.04
Pain B 0.67 p,0.0001 —
BSI global
severity index
20.22 p = 0.01 20.18 p = 0.04
BSI anxiety 20.11 p = 0.2 20.04 p = 0.7
BSI depression 20.11 p = 0.2 20.07 p = 0.4
BSI somatisation 20.28 p = 0.001 20.26 p = 0.001
Figure 4 (Top left) Median AML urge
thresholds: thresholds were significantly
higher in healthy controls than IBS subjects.
(Top right) The median urge report criterion
(B) to 30 mm Hg and 34 mm Hg stimuli: IBS
patients had a lower criterion which reflects
their increased tendency to report urge
irrespective of stimulus intensity. (Bottom left)
The median urge neurosensory sensitivity
(p(A)). There were no differences between
the two groups. (Bottom right) The
percentage of subjects whose ability to
discriminate urge sensations between
30 mm Hg and 34 mm Hg stimuli was better
than chance (p(A).0.5): there was no
difference between the two groups. The bars
on each graph represent the interquartile
range.
Table 3 Spearman’s correlations: AML urge threshold and
urge report criterion (B)
Correlation (rho) with
AML urge threshold
Correlation (rho) with SDT
urge report criterion (B)
Urge p(A) 20.22 p = .007 20.09 p = 0.3
Urge B 20.51 p,0.0001 –
BSI global
severity index
20.19 p = 0.03 20.18 p = 0.04
BSI anxiety 20.17 p = 0.05 20.15 p = 0.07
BSI depression 20.07 p = 0.4 20.12 p = 0.15
BSI somatisation 20.18 p = 0.04 20.16 p = 0.06
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thresholds are not equivalent with painful sensations since pain
reports are influenced by non-neurosensory factors such as
placebo, emotion, attention, and distraction.13
SDT is an alternative pain measurement technique that
separately quantifies the individual components of the pain
response: neurosensory sensitivity (p(A)), a measure of
neurosensory function based on the ability to discriminate
between stimuli; and report criterion (B), a measure of stoicism
based on the overall tendency to report pain.13 Importantly,
previous research has shown that only the criterion is
susceptible to changes in cognitive or psychological vari-
ables.13–15 The discrimination index, p(A), changes in response
to analgesic drugs but is not influenced by psychological
manipulations.15 16 In this study, IBS patients had similar pain
neurosensory sensitivity and lower pain report criterion
compared to healthy controls. In other words, their tendency
to report pain at lower thresholds related not to increased
neural sensitivity, but rather to their predilection towards
reporting pain.
Whereas SDT has been widely used in somatic pain research13
it has been used only rarely in previously published studies
on visceral pain sensitivity in functional gastrointestinal
disorders. Bradley et al observed lower AML pain thresholds,
similar neurosensory sensitivity, and decreased report criterion
for balloon distensions of the oesophagus in patients with
non-cardiac chest pain,22 which is similar to the findings of
this study. Whitehead et al observed lower AML pain thres-
holds and similar neurosensory sensitivity for rectal disten-
sions in women with IBS,19 which is also similar to the findings
of this study. However, they did not measure the report
criterion.
Similar to pain, our findings also suggest that lower AML
determined urge thresholds in patients with IBS are largely
explained by an increased tendency to report urge. However,
the finding that urge thresholds and urge neurosensory
sensitivity were inversely correlated (r = 20.22, p,0.005)
suggests that lower urge thresholds in IBS may also be
attributable—albeit to a lesser extent—to increased urge neuro-
sensory sensitivity. These findings contrast with those reported by
Corsetti et al who, using non-painful, barely perceivable balloon
distensions, found that patients with IBS had increased neuro-
sensory sensitivity and similar report criterion. However, unlike
our study, their study involved a small population (22 patients and
13 controls) in which there were no psychological differences
between the IBS and control groups.23
The increased tendency to report pain and urge in patients
with IBS may be the downstream result of multiple cognitive
and psychological processes. Firstly, patients with IBS appear to
be hypervigilant to gastrointestinal sensations.12 24 For example,
on functional brain imaging they show similar, abnormal
cortical responses to both actual and anticipated (sham)
distensions.25 26 Secondly, hypervigilance may reduce the
intensity at which they notice gut distensions28 and sensations.
Thirdly, once perceived, subjects with IBS interpret these
sensations through a generally negative schema (framework
for explaining reality),28 which leads them to attribute their
sensations to disease.29 Finally, disease attribution in turn
further increases attention to gastrointestinal symptoms30
through which a cycle of gastrointestinal sensory amplification
is ultimately established.31 Along these lines, in our study
somatisation was more common in IBS and was correlated
inversely with pain thresholds and directly with the response
criterion. This is similar to findings that in Gulf War veterans
with IBS, lower pain thresholds could be largely explained by
increased somatic focus.32 Other investigators have also found
that global psychological distress is correlated with the amount
of brain activation in response to painful rectal distension33 and
is inversely correlated with tolerance for painful balloon
distension of the rectum.34
In order to assess visceral sensitivity independently from
these cognitive processes, some have proposed measuring
cortical activity during subliminal distensions (that is, not
consciously perceived).35 36 Lawal et al used this approach and
found increased cortical activation in subjects with IBS. They
interpreted this as evidence for neural hypersensitivity that is
independent of cognitive input.37 However, it is unclear whether
these distensions were truly subliminal since most individuals
can perceive distensions as small as 5 mm Hg38; the distensions
in their study ranged from 10 mm Hg to 20 mm Hg. Secondly,
their observation that cerebral activation in IBS patients did not
increase in a positive dose-response fashion suggests that IBS
patients were globally hypersensitive at baseline. This global
hypersensitivity was attributed by Naliboff and Mayer to
cognitive and psychological processes such as uncertain
expectation and hypervigilance, that could not be completely
controlled for in the study.39
Although our data demonstrate that psychological phenom-
ena strongly influence pain thresholds, our experimental
methods may not have been sensitive enough to detect subtle
differences in neurosensory sensitivity. Thus, we cannot rule
out the effects of peripheral physiological mechanisms, such as
sensitisation of colonic afferent pathways.6 42 43 This afferent
hypersensitivity has been credited to inflammation based on
evidence that experimentally induced colonic inflammation
lowers rectal pain thresholds in animal models.42 Nonetheless,
inflammation has not been shown to explain lower thresholds
in IBD patients.43 44
Study limitations
Two potential limitations to this study were posed by the
repeated balloon distensions required by the SDT protocol.
Firstly, certain subjects failed to complete all 24 SDT trials
because of intolerable levels of pain or urge. We estimated the
effects of this by repeating our analyses without including those
subjects who completed fewer than half of the trials. The results
were the same. Secondly, the process of repeated very intense
colonic distensions (60 mm Hg) has been previously shown to
induce rectal hypersensitivity in subjects with IBS.8 We
estimated the effects of this by comparing the change in pain
intensity ratings between early and late stimuli in IBS patients
and healthy controls. There was no difference between the two
groups.
SDT, which quantifies the ability of subjects to discriminate
between very similar stimuli, required that we use stimulus
intensities that were very close to each other (30 mm Hg vs
34 mm Hg). This might have been too close to allow for
adequate discrimination—that is, the measurement of neural
sensitivity may have been insensitive. However, most subjects
can perceive a 5 mm Hg increase in stimulus intensity.19 In this
study 43% of both IBS patients and healthy controls were able
to discriminate between the 30 mm Hg and 34 mm Hg disten-
sions at better than chance levels (p(A) values above 0.5).
Calculation of the report criterion required us to use the same
stimuli for all subjects, irrespective of their AML thresholds. As
a result, the ability of some subjects to discriminate between
SDT stimuli might have been affected either because the test
stimuli were well above their pain threshold or they were so far
below their pain threshold that none of them were perceived as
painful. We tested for this by excluding subjects who rated all
stimuli as equally painful and repeating the analysis. The
results did not change. Furthermore, in our previous smaller
study where we individualised SDT stimulus intensities for
each patient based on their AML determined pain threshold
(though we did not compute a report criterion), we still found
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that subjects with IBS and healthy controls had similar
neurosensory sensitivity to pain.19
A theoretical limitation is that we used pressure rather than
volume based balloon distensions. Some investigators prefer
volume based distensions or indices that integrate pressure and
volume into estimates of wall tension.45 We followed the
recommendations of an international consensus committee46 by
scaling our distensions in pressure rather than volume because
it is recognised that volume thresholds are influenced by
muscle tone, which varies from hour to hour in response to
meal ingestion and anxiety. Individual differences in pain
thresholds are believed to be more stable and reproducible
when measured on a pressure scale rather than a volume scale.
Conclusion
These data show that lower pain and urge thresholds in
subjects with IBS are strongly influenced by cognitive and
psychological factors. Peripheral physiological events such as
inflammation42 and temporal summation8 have also been
shown to influence pain sensitivity. However, these data
suggest that, when explaining the differences between IBS
patients and healthy controls, the contribution of peripheral
physiological events may be relatively small compared to the
cognitive and psychological influences that are reflected in the
report criterion index, which reflects the generalised tendency
to report pain. The implications of this finding are far reaching.
Firstly, it underscores the importance of accounting for
psychological factors when interpreting tests of sensory
function. Secondly, it highlights the important part played by
centrally mediated processes in the pathophysiology of visceral
sensitivity in IBS and suggests that novel therapies for pain in
IBS should target centrally mediated mechanisms.
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Answer
From question on page 1190
The echocardiogram demonstrates a pericardial effusion with
cardiac tamponade. This resulted in ischaemic hepatitis (IH)
and acute liver failure (ALF). An emergency pericardiocentesis
was performed, and circulatory function immediately
improved. Liver and renal function normalised over the next
15 days (fig 1).
IH is an uncommon but well described cause of ALF. In this
case, ischaemic liver injury occurred because of a combination
of factors: right heart failure (acute hepatic congestion) and
decreased hepatic arterial perfusion, secondary to hypotension
from cardiac tamponade.
IH occurs in the setting of the following predisposing factors:
reduced hepatic arterial flow states, passive liver congestion
and arterial hypoxaemia. Aetiologies include cardiac arrest and
intraoperative hypotension (eg, cardiac bypass) on a back-
ground of respiratory or left ventricular failure.
Treatment aims at removing the insult to the liver and
maximising cardiac output, thus improving oxygenation.
Fulminant hepatic failure is uncommon, and usually occurs
with pre-existing cirrhosis. The condition is reversible, depend-
ing on the underlying cause of the circulatory insult. Because of
the setting of major circulatory failure (eg, cardiac arrest) and
good prognosis if circulation is restored, liver transplantation is
rarely indicated.
When presented with ALF, it is important to consider
ischaemia, a reversible condition. Although cardiac tamponade
is a rare cause of IH, this case demonstrates the benefit of early
diagnosis and removing the insult to the liver with resultant
rapid and complete clinical improvement of the IH.
doi: 10.1136/gut.2006.095547a
Figure 1 Graphs showing the biochemical changes in the reported case.
The acute rise and fall in alanine aminotransferase (ALT) and international
normalised ratio (INR), with a delayed rise in bilirubin, are characteristic of
ischaemic hepatitis. The arrows denote when pericardiocentesis was
performed.
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